Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Bill 119 s 735, also known as the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2021, aims to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program. The bill seeks to address the needs of individuals living with sickle cell disease by providing funding for research, surveillance, prevention, and treatment programs.

The legislation emphasizes the importance of early detection and intervention for individuals with sickle cell disease, as well as the need for increased access to quality care and treatment options. It also highlights the importance of improving data collection and surveillance efforts to better understand the impact of sickle cell disease on individuals and communities.

Additionally, the bill aims to support the development of new treatments and therapies for sickle cell disease, as well as to promote education and awareness about the disease among healthcare providers and the general public. The legislation also includes provisions to ensure that individuals with sickle cell disease have access to comprehensive care and support services. Overall, Bill 119 s 735 is focused on improving the lives of individuals living with sickle cell disease through increased research, prevention, and treatment efforts. By reauthorizing and expanding the sickle cell disease prevention and treatment demonstration program, the bill aims to make significant strides in addressing the needs of individuals with this chronic and often debilitating condition.